Patheon
Patheon’s Harry Gill, SVP, Quality and Continuous Improvement, will present 'Utilising Operational Excellence Principles to Drive Quality Improvements' on Wednesday 23 October at 2:30 p.m., CET on Stand 42L52.
During the presentation, Gill will discuss how the company’s Patheon Advantage II programme has been one of the main drivers of its efficiency improvement efforts. Patheon has utilised these same philosophies to create improvements in its quality performance, in particular right first time, which is a key performance indicator for both Patheon and its clients.
In addition, many Patheon executives, technical and scientific experts will also attend and be available to discuss Patheon’s non-sterile, sterile and softgel capabilities for development and commercial. Patheon’s experience encompasses thousands of projects for pharmaceutical and biotechnology companies of all types and sizes. The company gives access to the expertise, proven quality and global resources to bring drug candidates from preclinical stages through commercial production. Patheon will be exhibiting for the duration of the conference.
Stand 42G03
Patheon Inc., +1 919 226 3200, doingbusiness@patheon.com, www.patheon.com.